COVID-19 patients have at least one persistent symptom says studies. According to a report published in The Lancet journal, most of the COVID-19 patients are admitted to the hospitals to get treatment for at least one persistent symptom even after six months initially being tested positive.
The research examined at the long-term consequences of the global pandemic, COVID-19 infection around January and May and June and September in 1,733 patients first reported in Wuhan, China.
Many Hospitalised COVID-19 patients have at least one persistent symptom
In the research, scientists surveyed with patients face-to-face through questionnaires to evaluate their symptoms and health-related standard of living, along with those from Jin Yin-tan Hospital in China.
To assess their physical fitness, the discharged patients also performed physical assessments, lab tests, and a six-minute walking examination discovered that COVID-19 patients have at least one persistent symptom.
About 400 patients also undergone several other tests, along with an examination of their lung function, and a follow-up test was performed on 94 patients those whose blood antibody levels were registered at the height of the infection.
Muscle fatigue was perhaps the most common sign to persist, as per scientists (63 per cent of cases), with patients, reporting sleep difficulties often (26 per cent).
In 23 per cent of patients, anxiety and depression were recorded. The study found that admitted patients who were more often chronically ill had decreased lung function and reported lung examination abnormalities—which researchers assume may indicate organ failure six months after the initial infection.
The researchers stated that little is known about the long-term health impacts of COVID-19 since very few follow-up studies are performed in recovered patients so far.
For those who have been reported, they said, they were only able to look at a limited number of cases during a brief follow-up period.
“Our analysis indicates that most patients continue to live with at least some of the effects of the virus after leaving the hospital, and highlights a need for post-discharge care, particularly for those who experience severe infections,” said study co-author Bin Cao, from National Center for Respiratory Medicine, China-Japan Friendship Hospital in China.
“Our work also underscores the importance of conducting longer follow-up studies in larger populations to understand the full spectrum of effects that COVID-19 can have on people,” Cao said.
Research and Estimates
The researchers said the estimates were 29 per cent and 22 per cent, overall, for patients who required supplemental oxygen as well as those who did not require oxygen therapy. As per the analysis, in the six-minute walking examination, patients with a more serious illness performed worse.
The researchers discovered that during follow-up research, 76 per cent of patients experienced at least one persistent symptom. Lung function was commonly impaired in patients with more severe disease, with 56 per cent of those requiring respiratory assistance having a decreased flow of oxygen to the bloodstream from the lungs.
The scientists said 13 per cent of patients whose kidney function was normal while in the hospital had reduced kidney function in the follow-up.
The researchers said it’s not possible to determine if symptoms recorded throughout follow-up were persistent just after the infection worsened after treatment or persisted after discharge based on the way the data was analysed.
In order to evaluate differences in outcomes among inpatients and outpatients, the researchers believe more work is required.